SFS
ODT

Sowell Financial Services’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Sowell Financial Services’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000
Closed -$3K – 3115
2021
Q1 		$3K Buy
+1,000
New +$18.9K ﹤0.01% 2782
2020
Q3 		– Sell
-162
Closed -$7K – 2788
2020
Q2 		$7K Sell
162
-1,052
-87% -$34K ﹤0.01% 1822
2020
Q1 		$34K Sell
1,214
-891
-42% -$26K ﹤0.01% 1190
2019
Q4 		$68K Buy
+2,105
New +$65.2K 0.01% 1043

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sowell Financial Services's ODT Position: Q2 2021 in Review

Sowell Financial Services sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q2 2021, closing a stake of 1,000 shares — an estimated $3K sold.

Sowell Financial Services first reported a position in ODT in Q4 2019 and held it in 4 quarters. The position peaked at $68K in Q4 2019. 69 funds tracked by Wall St. Rank hold ODT as of Q2 2021.

  • Sowell Financial Services reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,000 Odonate Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $3K.
  • Sowell Financial Services first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Sowell Financial Services's Odonate Therapeutics, Inc. Common Stock position peaked at $68K in Q4 2019.
  • 69 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.